Centre for Global Health Research, Dalla Lana School of Public Health, St Michael's Hospital & University of Toronto, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada.
Asian Development Bank, Manila, Philippines.
Bull World Health Organ. 2020 Jan 1;98(1):19-29. doi: 10.2471/BLT.19.234252. Epub 2019 Oct 21.
To estimate the costs and mortality reductions of a package of essential health interventions for urban populations in Bangladesh and India.
We used population data from the countries' censuses and United Nations Population Division. For causes of mortality in India, we used the Indian Million Death Study. We obtained cost estimates of each intervention from the third edition of . For estimating the mortality reductions expected with the package, we used the model. We calculated the benefit-cost ratio for investing in the package, using an analysis based on the Copenhagen Consensus method.
Per urban inhabitant, total costs for the package would be 75.1 United States dollars (US$) in Bangladesh and US$ 105.0 in India. Of this, prevention and treatment of noncommunicable diseases account for US$ 36.5 in Bangladesh and U$ 51.7 in India. The incremental cost per urban inhabitant for all interventions would be US$ 50 in Bangladesh and US$ 75 in India. In 2030, the averted deaths among people younger than 70 years would constitute 30.5% (1027/3362) and 21.2% (828/3913) of the estimated baseline deaths in Bangladesh and India, respectively. The health benefits of investing in the package would return US$ 1.2 per dollar spent in Bangladesh and US$ 1.8 per dollar spent in India.
Investing in the package of essential health interventions, which address health-care needs of the growing urban population in Bangladesh and India, seems beneficial and could help the countries to achieve their 2030 sustainable development goals.
估算孟加拉国和印度城市人口基本卫生干预措施一揽子计划的成本和死亡率降低。
我们使用了来自两国人口普查和联合国人口司的数据。对于印度的死因,我们使用了印度百万死亡研究。我们从第三版 获取了每个干预措施的成本估算。为了估计该一揽子计划预期的死亡率降低,我们使用了 模型。我们使用基于哥本哈根共识方法的分析来计算投资该一揽子计划的效益成本比。
每个城市居民的总费用将分别为孟加拉国 75.1 美元(USD)和印度 105.0 美元。其中,非传染性疾病的预防和治疗占孟加拉国的 36.5 美元和印度的 51.7 美元。所有干预措施的每个城市居民增量成本分别为孟加拉国的 50 美元和印度的 75 美元。到 2030 年,70 岁以下人群的死亡人数将分别占孟加拉国和印度估计基线死亡人数的 30.5%(1027/3362)和 21.2%(828/3913)。投资该一揽子基本卫生干预措施的健康效益将在孟加拉国每投入 1 美元获得 1.20 美元的回报,在印度每投入 1 美元获得 1.80 美元的回报。
投资于基本卫生干预措施一揽子计划,以满足孟加拉国和印度不断增长的城市人口的医疗保健需求,似乎是有益的,并有助于两国实现 2030 年可持续发展目标。